Granza Bio
Building programmable therapeutics for the immune system
San Francisco , US
Synthetic Biology
Biotech
Healthcare
Therapeutics
Oncology
Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.
- Projects
- Team
- Jobs
- News
No projects yet.
This company hasn't published any projects. Be the first to launch one!
Create Your First ProjectFounded2024
Team Size7
LocationUS
Websitewww.granzabio.com/
🏳️
Claim This ListingIs this your company?
Claim this listing to manage your profile, add updates, and connect with your audience.